The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure

by IG Rekhtina, MV Nareiko, LP Mendeleeva
Published 2018-10-01

Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

by AA Novikova, GA Klyasova, EO Gribanova, VV Ryzhko, TA Tupoleva, LP Mendeleeva, VG Savchenko
Published 2019-03-01

Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

by MV Firsova, LP Mendeleeva, AM Kovrigina, MV Solov’ev, NL Deineko, MYu Drokov, VG Savchenko
Published 2019-09-01

Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

by MV Solov’ev, LP Mendeleeva, GA Yatsyk, NS Lutsik, MV Firsova, EG Gemdzhian, VG Savchenko
Published 2018-10-01

Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

by AV Petrov, DV Motorin, OS Pokrovskaya, ES Urnova, MV Nareiko, DV Babenetskaya, YuA Alekseeva, LL Girshova, LP Mendeleeva, AYu Zaritskii
Published 2017-07-01